CIDRAP newsletters options
Forty-seven states are seeing uncontrolled spread and 2 are trending poorly, leading several governors to impose new restrictions.
Separate reports detail shortages of rheumatoid disease treatments and of drugs in France.
Also, Iran's third surge hits record levels and Sweden orders some restrictions.
A PLOS One study yesterday showed that behavioral responses to the pandemic differ by age and change over time, with older people more likely to practice pandemic-mitigating behaviors—hygiene, quarantining, and physical distancing—and all age-groups demonstrating greater likelihood of engaging in risky behavior over time.
A study of community-level antibiotic use in patients in four low- and middle-income countries (LMICs) found frequent use of broad-spectrum antibiotics considered at risk of becoming ineffective owing to rising antibiotic resistance, an international team of researchers reported today in Clinical Microbiology and Infection.
The 7-day average of daily US cases is 108,694, a 37% increase from the week before.
The death rate in less-crowded homes was less than half that of homes with shared bedrooms and bathrooms.
A study yesterday found that employment-related exposure to SARS-CoV-2, the virus that causes COVID-19, endangers workers and their household members.
CARB-X announced today that it is awarding up to $2.05 million to Locus Biosciences of Morrisville, North Carolina, to develop a CRISPR-Cas3-enhaced bacteriophage for treating recurring urinary tract infections caused by Klebsiella pneumoniae.
Some people who were never infected with SARS-CoV-2 appear to have cross-reactive antibodies against it.
The Joe Biden-Kamala Harris transition website says it will immediately restore America's relationship with the World Health Organization.
Also, preliminary phase 3 data on Pfizer's COVID-19 vaccine candidate show 90% effectiveness.
Daily infectious disease (ID) consultation in an Italian hospital was associated with reduced antibiotic consumption compared with weekly ID consultation, Italian researchers reported late last week in BMC Infectious Diseases.
In a Mortality and Morbidity Weekly Report (MMWR) study today, data from the Premier Healthcare Database showed that, of 106,543 patients who survived after being admitted for COVID-19 from March through July, 9,504 (8.9%) were readmitted to the same hospital within 2 months of discharge for any condition, infectious disease–related or not.
New reports depict a resilient industry with more potential during COVID-19.
WHO experts said today that so far there's no sign the virus behaves differently, but more research is needed.
Extensive contact tracing found that frequent social interactions with extended family, plus the greater community, helped spread the virus.
A steep jump in cases yesterday comes as hospitals in some states are already feeling pressure, with experts saying the nation's COVID situation is likely to get worse.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The use of point-of-care C-reactive protein (CRP) tests in primary care practices reduced the odds of prescribing antibiotics for cough by 21%, a non-significant but clinically relevant reduction, researchers reported yesterday in Eurosurveillance.
